BSE MidCap Select PB	5.4
BSE MidCap Select PE	36.4
BSE MidCap Select DIV	0.6
BSE MidCap Select EPS	446.5

BSE MidCap Select News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on BSE MidCap Select from all sources in a single place.

Ashok Leyland Ltd.

18 Aug 2025, 10:55AM

131.75

8.03%

Ashok Leyland Stock Q1 ReviewNirmal Bang Maintains 'Buy', Says Margins To Expand On Better Mix, Pricing

NDTV Profit

A future demerger could unlock significant value for Ashok Leyland shareholders, crystallizing the EV business' high-growth potential, adds the brokerage.

Ashok Leyland Ltd.'s price crossed above 30Day SMA today

Ashok Leyland Ltd.

18 Aug 2025, 10:38AM

131.75

8.03%

AGM

Ashok Leyland Ltd - 500477 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Shareholders Meeting - August 14, 2025 Scrutinizer''s Report and evoting results

pdf

Max Healthcare Institute Ltd.

18 Aug 2025, 09:39AM

1222.90

0.18%

'Buy' Max Healthcare Shares Maintains PL Capital Post Inline Q1 Results Check Target Price

NDTV Profit

Max Healthcare's operational efficiency has also been commendable, especially in competitive markets like NCR, adds the brokerage.

Max Healthcare Institute Ltd. has gained 20.52% in the last 6 Months

Godrej Properties Ltd.

17 Aug 2025, 02:54PM

2004.40

3.50%

Godrej Properties net debt rises 42% to 4,637 cr in Q1, debt-equity ratio at 0.26

Business Line

Godrej Properties has been very aggressive in acquisition of land parcels in the last few years to build group housing projects as well as plotted development

Number of FII/FPI investors increased from 746 to 771 in Jun 2025 qtr.

Godrej Properties' net debt jumps 42% to 4,637 cr in Q1 amid expansion

Business Standard | 17 Aug 2025, 02:31PM

Aurobindo Pharma Ltd.

17 Aug 2025, 01:35PM

1075.80

-0.72%

Aurobindo Pharma expects China plant to break even at EBITDA level this year

Business Line

"This facility with an initial capacity of 2 bn units plus is ramping up as expected and will begin contributing to revenue in the coming quarters and is expected to break even at the EBITDA level by Q3 FY26"

Promoters pledged 0.16% of shares in last quarter. Total pledge stands at 17.08% of promoter holdings

Aurobindo Pharma expects China plant to break even at Ebitda level in FY26

Business Standard | 17 Aug 2025, 11:34AM

Dixon Technologies (India) Ltd.

16 Aug 2025, 11:07PM

16759.00

3.51%

Dixon Tech, China's HKC form 370 cr JV for display module manufacturing

Business Standard

Domestic electronics contract manufacturer Dixon Technologies has formed a Rs 370 crore joint venture for display modules manufacturing with Chinese company HKC Overseas. The Dixon Technologies-HKC Overseas joint venture is for manufacturing and selling of LCD and TFT-LCD modules that are used in electronic devices like TV, mobile phones etc for display, a regulatory filing said on Saturday. "Dixon Technologies (India) Ltd has entered into a Term Sheet with HKC Corporation Ltd to form a joint venture for manufacturing of Liquid Crystal Modules, thin film transistor liquid crystal display modules, assembly of end products such as smartphones, TVs, monitors and auto displays and selling HKC branded end products in India," the filing said. HKC Overseas Ltd will acquire 26 per cent stake in Dixon Display Technologies Pvt Ltd (DDTPL) for USD 10.998 million, about Rs 95.5 crore and Dixon will acquire 74 per cent stake in the JV for USD 31.3 million, about Rs 274 crore in two tranches. "T